Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hulkko, A.P.
Murray, G.K.
Moilanen, J.
Haapea, M.
Rannikko, I.
Jones, P.B.
Barnett, J.H.
Huhtaniska, S.
Isohanni, M.K.
Koponen, H.
Jääskeläinen, E.
and
Miettunen, J.
2017.
Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966.
European Psychiatry,
Vol. 45,
Issue. ,
p.
50.
Volavka, Jan
and
Vevera, Jan
2018.
Very long-term outcome of schizophrenia.
International Journal of Clinical Practice,
Vol. 72,
Issue. 7,
p.
e13094.
Kadra, G.
Stewart, R.
Shetty, H.
MacCabe, J. H.
Chang, C.‐K.
Taylor, D.
and
Hayes, R. D.
2018.
Long‐term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality.
Acta Psychiatrica Scandinavica,
Vol. 138,
Issue. 2,
p.
123.
Davidson, Michael
2018.
The debate regarding maintenance treatment with antipsychotic drugs in schizophrenia.
Dialogues in Clinical Neuroscience,
Vol. 20,
Issue. 3,
p.
215.
Hunter, Noël
2018.
Trauma and Madness in Mental Health Services.
p.
183.
Huhtaniska, Sanna
Korkala, Iikka
Heikka, Tuomas
Björnholm, Lassi
Lehtiniemi, Heli
Hulkko, Anja P.
Moilanen, Jani
Tohka, Jussi
Manjón, José
Coupé, Pierrick
Kiviniemi, Vesa
Isohanni, Matti
Koponen, Hannu
Murray, Graham K.
Miettunen, Jouko
and
Jääskeläinen, Erika
2018.
Antipsychotic and benzodiazepine use and brain morphology in schizophrenia and affective psychoses – Systematic reviews and birth cohort study.
Psychiatry Research: Neuroimaging,
Vol. 281,
Issue. ,
p.
43.
Moncrieff, Joanna
Lewis, Glyn
Freemantle, Nick
Johnson, Sonia
Barnes, Thomas R E
Morant, Nicola
Pinfold, Vanessa
Hunter, Rachael
Kent, Lyn J
Smith, Ruth
Darton, Katherine
Horne, Robert
Crellin, Nadia E
Cooper, Ruth E
Marston, Louise
and
Priebe, Stefan
2019.
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
BMJ Open,
Vol. 9,
Issue. 11,
p.
e030912.
Peritogiannis, Vaios
Grammeniati, Aikaterini
Gogou, Afroditi
Gioti, Panagiota
and
Mavreas, Venetsanos
2019.
Very Long-Term Outcome of Community-Dwelling Patients With Schizophrenia Spectrum Disorders in Rural Greece.
Journal of Nervous & Mental Disease,
Vol. 207,
Issue. 12,
p.
1012.
Moncrieff, Joanna
and
Steingard, Sandra
2019.
A critical analysis of recent data on the long-term outcome of antipsychotic treatment.
Psychological Medicine,
Vol. 49,
Issue. 5,
p.
750.
Zito, Michael F.
and
Marder, Stephen R.
2020.
Rethinking the risks and benefits of long-term maintenance in schizophrenia.
Schizophrenia Research,
Vol. 225,
Issue. ,
p.
77.
Oedegaard, Christine H.
Davidson, Larry
Stige, Brynjulf
Veseth, Marius
Blindheim, Anne
Garvik, Linda
Sørensen, Jan-Magne
Søraa, Øystein
and
Engebretsen, Ingunn Marie Stadskleiv
2020.
“It means so much for me to have a choice”: a qualitative study providing first-person perspectives on medication-free treatment in mental health care.
BMC Psychiatry,
Vol. 20,
Issue. 1,
Chafi, Yohannes Kifle
Amare, Tadele
Haile, Kelemua
Damene, Woynabeba
Tesfaye, Getaneh
Minichil, Woredaw
and
De Luca, Vincenzo
2020.
Prevalence and correlates of job loss among schizophrenia outpatients at St. AmanuelMental Specialized Hospital, Addis Ababa, Ethiopia; cross sectional study.
PLOS ONE,
Vol. 15,
Issue. 12,
p.
e0242352.
Peritogiannis, Vaios
Gogou, Afroditi
and
Samakouri, Maria
2020.
Very long-term outcome of psychotic disorders.
International Journal of Social Psychiatry,
Vol. 66,
Issue. 7,
p.
633.
Rangu, Neal
Frank-Pearce, Sumer G.
Alexander, Adam C.
Hébert, Emily T.
Ra, Chaelin
Kendzor, Darla E.
and
Businelle, Michael S.
2022.
Non-adherence to psychiatric medication in adults experiencing homelessness is associated with incurred concussions.
Frontiers in Human Neuroscience,
Vol. 16,
Issue. ,
Crellin, Nadia E.
Priebe, Stefan
Morant, Nicola
Lewis, Glyn
Freemantle, Nick
Johnson, Sonia
Horne, Rob
Pinfold, Vanessa
Kent, Lyn
Smith, Ruth
Darton, Katherine
Cooper, Ruth E.
Long, Maria
Thompson, Jemima
Gruenwald, Lisa
Freudenthal, Robert
Stansfeld, Jacki L.
and
Moncrieff, Joanna
2022.
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders.
BMC Psychiatry,
Vol. 22,
Issue. 1,
Rubio, Jose M
and
Perez-Rodriguez, Mercedes
2022.
Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?.
Schizophrenia Bulletin Open,
Vol. 3,
Issue. 1,
Lawrence, Ryan E.
Becker, Ina
and
McGorry, Patrick
2023.
Tasman’s Psychiatry.
p.
1.
Bergström, Tomi
Seikkula, Jaakko
Köngäs-Saviaro, Päivi
Taskila, Jyri J.
and
Aaltonen, Jukka
2023.
Need adapted use of medication in the open dialogue approach for psychosis: a descriptive longitudinal cohort study.
Psychosis,
Vol. 15,
Issue. 2,
p.
134.
Liddle, Peter F.
and
Sami, Musa B.
2024.
The Mechanisms of Persisting Disability in Schizophrenia: Imprecise Predictive Coding via Corticostriatothalamic-Cortical Loop Dysfunction.
Biological Psychiatry,
Davidson, Michael
and
Carpenter, William T
2024.
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence.
Schizophrenia Bulletin,
Vol. 50,
Issue. 1,
p.
14.
Comments
No Comments have been published for this article.